BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.
Expand access to healthcare for underserved - Strengthen K-12 teaching and learning in high need public, K-12 districts through high quality professional development - Cultivate a culture of equitable conservation across Georgia with a priority on the coast and the longleaf pine ecosystem
Our mission is to co-create a more just and equitable future by building partnerships with and investing in organizations making an impact in Metro Atlanta communities.
We do this by building trusting partnerships and investing primarily in nonprofits that focus their experience and expertise on promoting racial equity through their work.
